Pleural Mesothelioma 2024: Latest Treatments & Survivor Insights
Learn about the latest advances in treating pleural mesothelioma from nationally renowned pleural mesothelioma specialists Dr. J. Marie Suga and Dr. Jeffrey Velotta. Hear from 9-year mesothelioma survivor Michael Cole as he shares his experience from diagnosis to today.
Discover the latest advances in treating pleural mesothelioma. Get expert insights from two top pleural mesothelioma specialists and a 9-year pleural mesothelioma survivor.
-
J. Marie Suga, MDMedical Oncologist and Pleural Specialist
-
Jeffrey Velotta, MDThoracic Surgeon and Pleural Specialist
-
Michael Cole9-Year Pleural Mesothelioma Survivor
-
Sean Marchese, MS, RNOncology Medical Writer and Registered Nurse
What You’ll Learn During the Webinar
- Chemotherapy and surgery considerations for patients
- Current standards for pleural mesothelioma treatment
- New approaches to treating pleural mesothelioma
- Clinical trials for pleural mesothelioma patients
- Insight from a pleural mesothelioma survivor on the physical and mental effects of treatment
You’ll also receive access to the free Q&A session our experts hosted after the presentation.
Mesothelioma Experts You Can Trust
Drs. Suga and Velotta have spent years helping mesothelioma patients and their families. They know the ins and outs of mesothelioma treatment and stay updated with the latest research and trends on treating pleural mesothelioma patients.-
J. Marie Suga, MDDr. J. Marie Suga is an oncologist at Kaiser Permanente Vallejo Medical Center in California and the medical director for the Kaiser Permanente Clinical Trials Program. She specializes in treating patients with lung cancer, breast cancer, colorectal cancer and malignant pleural mesothelioma.
-
Jeffrey Velotta, MDDr. Jeffrey Velotta is a renowned thoracic surgeon at Kaiser Permanente Oakland Medical Center in California. He specializes in treating pleural mesothelioma, lung cancer and other thoracic conditions.
-
Michael ColeDiagnosed with pleural mesothelioma in 2015, Michael Cole initially underwent an extrapleural pneumonectomy and several rounds of chemotherapy. After a recurrence in 2018, Michael chose immunotherapy and radiation. Since then, he has had only slow tumor changes and no new growth.
-
Sean Marchese, MS, RNAs a registered nurse with more than 20 years of clinical experience and more than six years in clinical research, Sean Marchese has planned and led oncology clinical trials involving immunotherapy, chemotherapy, radiation therapy and tumor treating fields. He has been a member of the American Nurses Association since 2017.